Methods for determining disorders by assaying for a non-tyrosina

Details Methods for determining disorders by assaying for a non-tyrosina Methods for determining disorders by assaying for a non-tyrosina

1998-01-16

1998-11-17

Wax, Robert A.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

435 71, 435 724, 514 12, 530350, 536 235, 424 9371, 424 9372, G01N 33574, G01N 3353, A61K 3800, C07H 2104

Patent

active

058374760

ABSTRACT:
The invention relates to nucleic acid molecules coding for a tumor rejection antigen precursor. Specifically, the tumor rejection antigen precursor, or `TRAP", is processed into at least one tumor rejection antigen, which is presented by HLA-A2 molecules. Ramifications of the discovery are also set forth.

REFERENCES:
patent: 5530096 (1996-06-01), Wolfel et al.
patent: 5683886 (1997-11-01), Van Der Bruggen et al.

Affiliated with

Also associated with

Rating

Methods for determining disorders by assaying for a non-tyrosina does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for determining disorders by assaying for a non-tyrosina, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for determining disorders by assaying for a non-tyrosina will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-883001